Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study - Wikidata - wikimedia - TriplyDB

Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study

Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study

http://www.wikidata.org/entity/Q34409710

about

Clinical management of advanced schistosomiasis: a case of portal vein thrombosis-induced splenomegaly requiring surgery.Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis.

P2860

Q33802086-2BDAE286-65CF-42C4-AEDB-4CA8B8BF57E7 Q34428788-B0728A78-2F29-4CD1-9C23-A2695758E6E8

P2860

Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study

http://www.wikidata.org/entity/Q34409710

description

1996 nî lūn-bûn

@nan

1996 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@ast

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@en

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@nl

type

label

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@ast

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@en

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@nl

prefLabel

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@ast

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@en

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@nl

P1433

Q34409710-B900FE9F-77E0-40D1-9809-D07C4D40D6CA

P1476

Q34409710-B8E41E3F-DC8B-43E9-8A95-D712A152D811

P2093

Q34409710-349EE064-21D7-475C-95A0-06031286FD44

Q34409710-85537C71-F705-4993-BE7C-DC9C7C02930D

Q34409710-897B4B56-B5F0-4D89-A599-5645858BAED8

Q34409710-9B093726-565E-4E82-94C4-A814B4676684

Q34409710-9C1D9ABB-1ACC-4245-8685-57C0B1CE0438

Q34409710-F21077CD-856A-4618-BC01-C6178D9ED113

P2860

Q34409710-0F787812-B1D6-4707-A52B-659E6105A36B

Q34409710-137C6DA9-455D-46CB-ABAB-D8F1411682AA

Q34409710-2A3CC1EE-DDA3-4A07-917F-9A6060F3D10D

Q34409710-53FB6C5C-753D-49AC-8109-5515239CABAC

Q34409710-5C313554-62FF-4A19-A72D-A503EC71606E

Q34409710-6E5F964A-8AE6-4D25-BF49-FE59390B8214

Q34409710-6EED4E3E-F611-49D1-B006-E2D3CF2628EC

Q34409710-815F733A-2CDF-4BE2-909D-E5FEE2C627D1

Q34409710-949FE6FF-DB22-496A-A23D-02FE2E7D1F73

Q34409710-9CBC3E46-5669-4E6E-A3FF-83D9E308A589

P304

Q34409710-CB4F52B0-C059-4952-B308-32F3DD75944C

P31

Q34409710-2A1574F2-047A-4E11-9D94-D0C6188B55B7

P356

Q34409710-B3AEBE5D-4290-4833-AC7C-33268B4A2355

P407

Q34409710-FEBAC10F-3AB1-46E7-801A-10F849E581DD

P433

Q34409710-1E89CCA2-9E29-4C31-A4CB-785B9411CEB0

P478

Q34409710-E387801F-1238-4F2F-B933-376F03FAEF39

P577

Q34409710-AD5B5A68-2D15-43C0-9B28-3D9310C197E6

P5875

Q34409710-B9B9D229-7D1D-46F2-B2C3-390CF1E948F2

P698

Q34409710-22C4437A-601F-42F6-B602-CBCF1FC92E4D

P932

Q34409710-62D0BE7F-4289-4235-9E3D-F73147B7773C

P356

P1433

P1476

Sclerotherapy versus sclerothe ...... al varices: a randomised study

@en

P2093

Awad M

http://www.w3.org/2001/XMLSchema#string

Azzam F

http://www.w3.org/2001/XMLSchema#string

Elsayed SS

http://www.w3.org/2001/XMLSchema#string

Farag FM

http://www.w3.org/2001/XMLSchema#string

Hamid M

http://www.w3.org/2001/XMLSchema#string

Shiha G

http://www.w3.org/2001/XMLSchema#string

P2860

Precipitation of hepatic encephalopathy by propranolol in cirrhosis

The surgeon's role in the management of portal hypertension.

Clinical pharmacokinetics of propranolol.

[Prospective controlled study of elective sclerotherapy plus oral propranolol for prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage].

Comparison of three nonsurgical treatments for bleeding esophageal varices.

Propranolol in chronic liver disease: a controlled trial of its effect and safety over twelve months.

Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis.

Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration.

Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.

Randomized controlled trial of injection sclerotherapy for bleeding oesophageal varices--an interim report.

P304

770-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.38.5.770

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

1996-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14495477

http://www.w3.org/2001/XMLSchema#string

P698

8707127

http://www.w3.org/2001/XMLSchema#string

P932

1383163

http://www.w3.org/2001/XMLSchema#string